A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer
Clinical trial NCT05067140 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05067140
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-02
- Primary completion
- 2027-05-25
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.